Information
-
Trademark
-
98354380
-
International Classifications
-
Filing Date
January 12, 2024
a year ago
-
Transaction Date
March 04, 2025
6 days ago
-
Status Date
March 04, 2025
6 days ago
-
Published for Opposition Date
March 04, 2025
6 days ago
-
Location Date
February 13, 2025
25 days ago
-
Status Code
686
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
CHUO, EMILY
-
Attorney Docket Number
NEUB 2401109
Attorney Name
Allison Strickland Ricketts
Law Office Assigned Location Code
L10
-
Owners
Case File Statements
- DM0000: The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell. The lines appear left to right in a gradient of color from purple to orange to yellow.
- GS0051: pharmaceutical preparations for human use for the treatment of adrenal insufficiency; pharmaceutical preparations for human use for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for human use for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
- CC0000: The color(s) purple, orange, and yellow is/are claimed as a feature of the mark.
- GS0441: Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
- GS0421: providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results
Case File Event Statements
-
1/12/2024 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
5/5/2024 - 10 months ago
4 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
5/5/2024 - 10 months ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
5/5/2024 - 10 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
5/15/2024 - 9 months ago
5 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/30/2024 - 9 months ago
6 - PRIORITY ACTION WRITTEN
Type: CPRA
-
5/30/2024 - 9 months ago
7 - PRIORITY ACTION E-MAILED
Type: GPRA
-
5/30/2024 - 9 months ago
8 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
7/31/2024 - 7 months ago
9 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Type: XELR
-
8/27/2024 - 6 months ago
14 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Type: XELR
-
7/31/2024 - 7 months ago
10 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Type: XELG
-
8/15/2024 - 6 months ago
12 - PRIORITY ACTION E-MAILED
Type: GPRA
-
8/15/2024 - 6 months ago
13 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
8/15/2024 - 6 months ago
11 - PRIORITY ACTION WRITTEN
Type: CPRA
-
8/27/2024 - 6 months ago
15 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Type: XELG
-
2/7/2025 - a month ago
18 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
2/7/2025 - a month ago
17 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
2/7/2025 - a month ago
16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/12/2025 - 26 days ago
19 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
2/26/2025 - 12 days ago
20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
3/4/2025 - 6 days ago
21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
3/4/2025 - 6 days ago
22 - PUBLISHED FOR OPPOSITION
Type: PUBO